Amazon Great Indian Festival 2020 - Electronics
Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Amazon Great Indian Festival 2020 - Electronics

| More

Granules India receives ANDA approval - Angel Broking

Posted On: 2020-09-24 23:55:41

Mr. Yash Gupta, Equity Research Associate, Angel Broking Ltd

Granules India Limited announced today that the US Food & Drug Administration (US FDA) has approved its Abbreviated New Drug Application (ANDA) for Naproxen Sodium and Diphenhydramine Hydrochloride Tablets, 220 mg/25 mg (OTC), generic equivalent of Aleve PM Tablets, 220 mg/25 mg, of Bayer HealthCare LLC. Naproxen Sodium and Diphenhydramine Hydrochloride Tablets are used for relief of occasional sleeplessness associated with minor aches and pains and to help you fall asleep and stay asleep. Granules now has a total of 31 ANDA approvals from US FDA (29 Final approvals and 2 tentative approvals). This is a good addition to the company portfolio and positive devolvement for the company.

Shares of GRANULES INDIA LTD. was last trading in BSE at Rs.361 as compared to the previous close of Rs. 363.45. The total number of shares traded during the day was 290450 in over 7150 trades.

The stock hit an intraday high of Rs. 368 and intraday low of 350. The net turnover during the day was Rs. 105141185.

Source: Equity Bulls

Click here to send ur comments or to

Amazon Great Indian Festival 2020 - Mobiles

Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only., its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.

Other Headlines:

Equitas Small Finance Bank Limited - Strongly developing from a microfinance to small bank... - Geojit

Britannia Industries - Q2FY21 Results - Angel Broking

Rallis India - Q2FY21 Results - Angel Broking

Equitas Small Finance Bank - IPO Note - Angel Broking

ACC Ltd - Q3CY20 Result - Angel Broking

Oberoi Realty - Q2FY21 Result - Angel Broking

Tata Communications - Q2FY21 Result - Angel Broking

India trade deficit for September 2020 - Angel Broking

Route Mobile - 19th October 2020 - Angel Broking

Thomas Cook India and SOTC partner with Accor - Launch Holiday Safe

Alembic Pharmaceuticals - USFDA approval for Amantadine Hydrochloride Tablets - Angel Broking

Maintain REDUCE on Avenue Supermarts - Recovery tracking well - HDFC Securities

HDFC Bank - Q2FY21 Result - Angel Broking


Bajaj Consumer Care - Faster-than-expected recovery - ICICI Securities

HCL Technologies - Strong quarter; modest near-term outlook - ICICI Securities

Shoppers Stop - Strengthening balance sheet & inducting new MD - ICICI Securities

Alkem Laboratories - Outlook remains strong - ICICI Securities

Media - BARC rating - Season of non-fiction tent poles - ICICI Securities

Prestige Estates Projects Ltd - All eyes on annuity assets - ICICI Securities

Federal Bank - Effectively navigating the cycle; structurally strengthening franchise - ICICI Securities

Logistics - Technology to drive efficiency, network benefits and eventually profitability - ICICI Securities

Economy - State-wise inflation analysis shows demand shock is outweighing supply shock in geographies with higher spread of Covid-19

HDFC Bank - Q2FY21 Result Update - ICICI Securities

Amber Enterprises India - Company Update - ICICI Securities

Phillips Carbon Black - Q2FY21 Company Update - ICICI Securities

Federal Bank - Q2FY21 Result Update - ICICI Securities

Oberoi Realty - Q2FY21 First Cut - ICICI Securities

Oil & Gas - Q2FY21 Result Preview - ICICI Securities

HCL Technologies - Q2FY21 Result Update - ICICI Securities

Avenue Supermarts - Q2FY21 Company Update - ICICI Securities

Gladiator Stocks - Jindal Stainless : Two years consolidation breakout signifies resumption of primary up trend...

HDFC Bank Q2FY21 Results - Retain BUY with PT Rs1500 - Call Highlights & YES SECURITIES View

Avenue Supermarts (DMart) - Q2FY21RU - Mr. Himanshu Nayyar, YES SECURITIES

Maintain BUY on Federal Bank - Operating performance surprises - HDFC Securities

Maintain BUY on HCL Technologies - Growth vectors intact - HDFC Securities

HCL Technologies - Q2FY21 First Cut - ICICI Securities

Cyient Ltd - Q2FY21 Company Update - ICICI Securities

Federal Bank - Q2FY21 First Cut - ICICI Securities

Phillips Carbon Black Ltd - Q2FY21 - Angel Broking

Zydus Cadilla - USFDA approval for Fingolimod - Angel Broking

Maintain ADD on Cyient - Getting back on track - HDFC Securities

Astrazeneca Pharma - Oct 16, 2020 - Angel Broking

Persistent Systems Limited - Oct 16, 2020 - Angel Broking

Maintain ADD on Mindtree - Improved operating profile - HDFC Securities

Cyient - Q2FY2021 numbers - Angel Broking

Auditor resignation in UPL - Angel Broking

HCL Tech - Q2FY2021 Results - Angel Broking

Mindtree - Q2FY2021 Result - Angel Broking

Cement Sector - Oct 15, 2020 - Angel Broking

Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019